Replies to post #358157 on NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

Anything to downplay...

[learningcurve2020]

If NWBO were going to be worth 15,20, or 25 billion as some here claim, wouldn't it have made more sense for NWBO to buy Cognate instead of letting the proclaimed "Secret Sauce" out of their hands?

[GoodGuyBill]

Of Course cognate has the ability to scale to some extent...but not to the same extent that could easily be achieved with CRL. Given CRL's world-wide locations, and their contacts/relationships with RAs in over 17 countries (and 16 states within the U.S.), it seems ludicrous to suggest the CRL buyout of Cognate would not be extremely beneficial to NWBO if DCVax-L is approved.

And since you focused on statements released by CRL, did you here the CEO (video embedded below) say:

the vast majority of work being done now is in oncology and there are obviously there have been enormous breakthroughs in oncology BECAUSE OF IMMUNOTHERAPY (2:10)

or that

CRL supported the development of approx. 85% of the drugs approved by the FDA in 2019 (4:35)

It is possible that none of this has anything to do NWBO and that the p3 trial failed (hell it's also possible that new variant of covid will wipe out mankind). But, the question is is this position probable or reasonable given ALL of the info we have. Hell NO! It isn't probable or reasonable at all!

I think, despite the horrific handling of the TLD announcement, longs have a whole lot to be excited about.